Keyword

netakimab

Description: A therapeutic monoclonal antibody targeting interleukin-17A, used to treat inflammatory diseases including psoriasis and spondyloarthritis.
OpenAlex ID: keywords/netakimab
2021 · Sergey N. Avdeev, Natalia V. Trushenko, et al. · Cytokine · 48
2019 · Paolo Gisondi, Davide Geat, et al. · Current Opinion in Pharmacology · 48
2021 · Fabiola Atzeni, Antonio Carriero, et al. · ImmunoTargets and Therapy · 44
2020 · T. V. Korotaeva, V. I. Mazurov, et al. · Rheumatology Science and Practice · 30
2025 · Dahyeon Kim, Seanna Yang, et al. · American Journal of Clinical Dermatology · 27
2022 · Sunil Dogra, Hitaishi Mehta · Expert Opinion on Biological Therapy · 22
2021 · Chongru He, Chenchen Xue, et al. · Journal of Clinical Pharmacy and Therapeutics · 21
2021 · Roman Maslennikov, Vladimir Ivashkin, et al. · European Cytokine Network · 18
2020 · Olga Yu. Olisova, Ekaterina M. Anpilogova · Vestnik dermatologii i venerologii · 15
2021 · T. V. Korotaeva, V. I. Mazurov, et al. · Rheumatology Science and Practice · 13
2022 · Olga Kostareva, Arina Svoeglazova, et al. · International Journal of Molecular Sciences · 12
2022 · L. S. Kruglova, N. S. Rudneva, et al. · Medical alphabet · 11
Works count: 153
Citation count: 878
Year
Topic
Type